Your browser doesn't support javascript.
loading
Estrogen Receptor Pathway Activity Score to Predict Clinical Response or Resistance to Neoadjuvant Endocrine Therapy in Primary Breast Cancer.
Inda, Márcia A; Blok, Erik J; Kuppen, Peter J K; Charehbili, Ayoub; den Biezen-Timmermans, Eveline C; van Brussel, Anne; Fruytier, Sevgi E; Meershoek-Klein Kranenbarg, Elma; Kloet, Susan; van der Burg, Bart; Martens, John W M; Sims, Andrew H; Turnbull, Arran K; Dixon, J Michael; Verhaegh, Wim; Kroep, Judith R; van de Velde, Cornelis J H; van de Stolpe, Anja.
Afiliación
  • Inda MA; Philips Research, Eindhoven, the Netherlands. marcia.inda@philips.com.
  • Blok EJ; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.
  • Kuppen PJK; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.
  • Charehbili A; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.
  • den Biezen-Timmermans EC; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.
  • van Brussel A; Philips Molecular Pathway Dx, Eindhoven, the Netherlands.
  • Fruytier SE; Philips Research, Eindhoven, the Netherlands.
  • Meershoek-Klein Kranenbarg E; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.
  • Kloet S; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.
  • van der Burg B; Leiden Genome Technology Center, Leiden University Medical Center, Leiden, the Netherlands.
  • Martens JWM; BioDetection Systems, Amsterdam, the Netherlands.
  • Sims AH; Medical Oncology, Erasmus MC, Rotterdam, the Netherlands.
  • Turnbull AK; Applied Bioinformatics of Cancer, University of Edinburgh Cancer Research UK Centre, MRC Institute of Genetics and Molecular Medicine, Edinburgh, United Kingdom.
  • Dixon JM; Applied Bioinformatics of Cancer, University of Edinburgh Cancer Research UK Centre, MRC Institute of Genetics and Molecular Medicine, Edinburgh, United Kingdom.
  • Verhaegh W; Edinburgh Breast Unit, Western General Hospital, Edinburgh, United Kingdom.
  • Kroep JR; Edinburgh Breast Unit, Western General Hospital, Edinburgh, United Kingdom.
  • van de Velde CJH; Philips Research, Eindhoven, the Netherlands.
  • van de Stolpe A; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.
Mol Cancer Ther ; 19(2): 680-689, 2020 02.
Article en En | MEDLINE | ID: mdl-31727690
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias de la Mama / Receptores de Estrógenos / Antineoplásicos Hormonales / Terapia Neoadyuvante Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias de la Mama / Receptores de Estrógenos / Antineoplásicos Hormonales / Terapia Neoadyuvante Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos